A
Alnylam Pharmaceuticals
Cambridge, United States
Founded 2002 NASDAQ: ALNY
About
Pioneer in RNAi therapeutics with lipid nanoparticle delivery
Company Details
- Type
- public
- Employees
- 2000+
- Funding
- Public
Key Products
- Onpattro
- Givlaari
- RNAi Drugs